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The identiﬁcation of gene–phenotype relationships is very important for the treatment of human
diseases. Studies have shown that genes causing the same or similar phenotypes tend to interact with
each other in a protein–protein interaction (PPI) network. Thus, many identiﬁcation methods based on
the PPI network model have achieved good results. However, in the PPI network, some interactions
between the proteins encoded by candidate gene and the proteins encoded by known disease genes
are very weak. Therefore, some studies have combined the PPI network with other genomic information
and reported good predictive performances. However, we believe that the results could be further
improved. In this paper, we propose a new method that uses the semantic similarity between the candi-
date gene and known disease genes to set the initial probability vector of a random walk with a restart
algorithm in a human PPI network. The effectiveness of our method was demonstrated by leave-one-out
cross-validation, and the experimental results indicated that our method outperformed other methods.
Additionally, our method can predict new causative genes of multifactor diseases, including
Parkinson’s disease, breast cancer and obesity. The top predictions were good and consistent with the
ﬁndings in the literature, which further illustrates the effectiveness of our method.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Because many diseases, such as cancer, diabetes, and
cardiovascular diseases, result from gene mutations, exploring
the relationships between diseases and their causative genes has
become an important topic in contemporary systems biology.
These gene mutation-caused diseases are very common in devel-
oped countries and are becoming increasingly common in develop-
ing countries [1].
Linkage analyses and association studies have been proposed to
identify disease genes [2–4]. However, the efforts of these methods
result in genomic intervals of 0.5–10 cM that are composed of hun-
dreds of genes [5,6]. Whether these genes are disease-causing
requires further investigation.
In recent years, with the rapid accumulation of different types
of genomic data, many calculation methods for prioritizing disease
genes have been proposed. One remarkable advantage of these cal-
culation methods is the reduction in manpower and material
resources. Concretely, most of these methods are based on similar-
ities between the genomic data of known disease genes and thegenomic data of the candidate gene. The genomic data include
sequence-based features [7,8], gene ontology (GO) annotation
information [9,10], expression patterns [11–13], and protein inter-
action data [14,15]. In most cases, multiple sources of genomic
data are combined to ﬁnd causal genes, e.g., the combinations of
GO annotation information with protein interaction data [16], GO
annotation information with sequence-based features [17], and
metabolic pathway data with protein interaction data [18].
Investigation of the interactions between the proteins that are
encoded by genes in the human PPI network has become one of
the primary and most powerful approaches for elucidating the
molecular mechanisms that underlie complex diseases [19–21].
Such exploration has often been performed by comparing the net-
work topology similarities of the nodes in the PPI network. There
are many methods for measuring topological similarity, including
calculating the number of common neighbors between two net-
work nodes and calculating the distance between two network
nodes. Due to incomplete data about the PPI network, some inter-
actions between the proteins encoded by candidate gene and the
proteins encoded by known disease genes are very weak. Thus,
some candidate genes cannot be well identiﬁed. To achieve better
prediction results, some studies have combined the PPI network
with phenotype similarity information and reported good perfor-
mances. However, we believe that the results could be further
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describe the molecular function of genes or the biological pro-
cesses in which the genes are involved. These data form the seman-
tic information of a gene. If a candidate gene and a disease gene
share a high level of semantic similarity, we can compensate for
the weak interaction between the genes in the PPI network by add-
ing the semantic similarity. Some studies have shown that GO
annotation information, which is used to predict disease genes
[22], is a very effective semantic resource. Based on these two
types of data sources, i.e., protein interaction data and GO annota-
tion information, this paper proposes a new method for inferring
gene–phenotype relationships. We use the semantic similarity
value between the candidate gene and known disease genes to
set the initial probability vector of the random walk with restart
(RWR) algorithm and apply this algorithm to the PPI network.
When the ﬁnal walk reaches a stable state, we predict new disease
genes according to the candidate genes’ rankings in the vector. We
used leave-one-out cross-validation to demonstrate the effective-
ness of our method. Compared with other methods, our method
achieved better performance. Additionally, new causative genes
of multifactor diseases, including Parkinson’s disease, breast can-
cer, and obesity, are predicted with our method. The top predic-
tions were good and consistent with the reports in the literature,
which further illustrates the validity of our method.Fig. 1. A schematic illustration of the HRSS algorithm.2. Materials and methods
2.1. Data source
Gene ontology data (released in October 2013) and a human
gene annotation dataset (released in October 2013) were from
the Gene Ontology database [23]. The GO consists of three struc-
tured ontologies, i.e., biological process (BP), molecular function
(MF), and cellular component (CC). The GO data contains 25,571
BP, 9661 MF, and 3386 CC terms. The gene annotation dataset con-
tained 383,316 annotations of 18,911 genes.
In this paper, PPI data were downloaded from the Human
Protein Reference Database (HPRD). All of the information in the
HPRD has been manually extracted from the literature by expert
biologists who have read, interpreted, and analyzed the published
data.
Disease–gene association data were obtained from the Online
Mendelian Inheritance in Man (OMIM) database [24].
2.2. Summaries of the RWR and HRSS algorithms
The RWR is a sorting algorithm [14] that simulates a random
walker that either starts from a seed node, or from a set of seed
nodes, and moves to its direct neighbors randomly at each step.
Finally, based on the probability of the random walker reaching a
speciﬁc node, we ranked all of the nodes in the graph. We used P0
to represent the initial probability vector, and Ps is a vector that rep-
resents the probability of the random walker reaching all nodes on
the graph at step s. The probability vector at step s + 1 is given by
Psþ1 ¼ ð1 dÞMPs þ dP0 ð1Þ
The row-normalized adjacency matrix of the graph is repre-
sented by parameter M.
The parameter d 2 ð0;1Þ is the restart probability. At each step,
the randomwalker can return to the seed nodes with probability d.
After some steps, the vector Psþ1 will reach a steady state. This
steady state is obtained by performing the iteration until the abso-
lute value of the difference between Ps and Psþ1 falls below 10
6.
jPsþ1  Psj < 106 ð2ÞThis paper used the HRSS algorithm (Fig. 1) that was developed
by Wu [25] to measure the semantic similarity.
The information content (IC) is deﬁned by Eq. (3),
ICðcÞ ¼  log pðcÞ ð3Þ
The probability of the occurrence of the term c in a speciﬁc cor-
pus is represented by component pðcÞ.
The IC-based distance between the two terms u and v is deﬁned
in Eq. (4), where v is a descendant of u.
distICðu; vÞ ¼ ICðvÞ  ICðuÞ ¼ log pðuÞ  log pðvÞ ð4Þ
Then, the IC-based speciﬁcity of the most informative common
ancestor (MICA) of any two terms termi and termj is
aIC ¼ distICðroot;MICAÞ ¼  log pðMICAÞ ð5Þ
The distIC between a term and the most informative leaf nodes
(MIL) descending from the term refers to the generality of a term.
Component b represents the average of the generality values of
termi and termj.
bIC ¼
distICðtermi;MILiÞ þ distICðtermj;MILjÞ
2
ð6Þ
The most informative leaf nodes of termi and termj are repre-
sented by MILi and MILj, respectively.
HRSSðtermi; termjÞ ¼ 11þ c
aIC
aIC þ bIC
ð7Þ
where c is deﬁned as follows:
c ¼ distðMICA;termiÞ þ distðMICA;termjÞ ð8Þ
Let g1 and g2 be two genes of interest and tg1 and tg2 the sets of all
of the GO terms assigned to gene g1 and g2, respectively.
HRSSGOMAXðg1; g2Þ ¼maxgoi2tg1
goj2tg2
ðHRSSðgoi; gojÞÞ ð9Þ
Table 1
Comparison of the RWR and DP_LCC methods.
Method ALI Rand
RWR 0.8084 0.8228
DP_LCC 0.8255 0.8387
RWRAHRSS 0.8615 0.8846
RWRMHRSS 0.8455 0.8701
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similarity
Different information contents of the genes’ GO terms and the
positional relationship between the genes’ GO terms in the direc-
ted acyclic graph were used to measure the semantic similarity
between two genes. A GO term describes gene information that
includes molecular functions, biological processes, and cellular
components. Therefore, the greater the semantic similarity shared
by genes the more functional similarity they share.
There is a relationship between two connected nodes in the PPI
network. This type of relationship is reﬂected by factors related to
chemical biology, signal transduction, genetic network, metabo-
lism etc. Therefore, nodes that share topological similarity share
synergy and similarity in the above aspects. Moreover, genes that
share semantic similarity are similar to each other in terms of
molecular functions, biological processes, and cellular components.
Therefore, both the topological similarity and the semantic similar-
ity reﬂect functional information and complement each other.
Researchers have found that similar phenotypes are essentially
caused by functionally related genes [26]. Based on this theory, we
used the maximum value and the average value of the semantic
similarity between the candidate gene and known disease genes
to set the initial probability vector for the RWR. The initial proba-
bility vector of a disease was constructed in such a manner that we
assigned the position value of the causative gene of the as 1. The
position value of the candidate gene was between 0 and 1, and it
was according to the semantic similarity value between the candi-
date gene and the causative gene. Next, we used the RWR algo-
rithm in the PPI network to measure the topological similarity.
In our method, the location value of the candidate gene in the
initial probability vector P0 for a speciﬁc disease can be calculated
with formula (10) or formula (11). The HRSS algorithm was used to
measure the semantic similarity between the candidate gene and
known disease genes.
MHRSSðgÞ ¼max
gi2G
ðHRSSGOMAXðg; giÞÞ ð10Þ
AHRSSðgÞ ¼
Pn
i¼1gi2G;HRSS
GO
MAXðg; giÞ
n
ð11Þ
The component g is a candidate gene, and G is known disease genes
set of the disease.
Now that there are two ways to set the initial probability vector
P0, our method has two according branches. The ﬁrst is the combi-
nation of the RWR and MHRSS (RWRMHRSS), and the second is the
combination of the RWR and AHRSS (RWRAHRSS).
3. Results
In this section, we ﬁrst compare the performance of our method
with other methods. Next, we explore the inﬂuence of d on our
method. Finally, we use our algorithm to predict new causative
genes for some multifactor diseases. The set of test genes was con-
structed in two ways. The ﬁrst was via the artiﬁcial linkage interval
(ALI) approach that assumes that one of the real disease-causing
genes does not interact with the disease and constructs the test
genes’ set with this disease-causing gene and its nearest 99 genes
in the chromosome. The second was via a validation against ran-
dom genes (Rand) approach. With the same assumption men-
tioned for the ALI approach, the Rand approach selects one of the
real disease-causing genes and 99 control genes randomly from
all genes in the interactome as the test gene set. The performance
of our method for recovering disease–gene relationships was
examined with leave-one-out cross-validation. In each round of
validation, we removed a disease–gene link. The remainingcausative genes for the disease were used as the seed nodes.
Receiver operating characteristic (ROC) curves were used to com-
pare the performance of our algorithm with those of other meth-
ods. ROC curve plot the sensitivity versus 1 – the speciﬁcity
based on a threshold that separates the prediction classes [11].
The area under ROC curve (AUC) indicates the performance of
the algorithm.
3.1. Comparison with other methods
To prove the validity of our method, we compared the perfor-
mance of our method with those of two other methods, i.e., the
RWRmethod [14] and the DP_LCC method [27]. The three methods
used the same dataset (i.e., the HPRD and OMIM databases) and the
same test method (leave-one-out cross-validation). In total, there
were 34,364 interactions among the 8919 genes in the gene net-
work. The phenotype similarity network included phenotype sim-
ilarities for 5080 diseases. There were 1428 gene–phenotype links
between 937 genes and 1216 phenotype entities. As we needed to
use the semantic information of the seed genes, only the pheno-
types associated with at least two disease genes were considered
in our experiment. A total of 168 phenotypes associated with
470 disease genes were obtained. The largest AUC for the DP_LCC
algorithm was found when the restart probability was set to 0.7,
and the weight was set to 0.5 [27]. Therefore, we set d ¼ 0:7.
Table 1 shows the AUC values of the four methods. These values
indicated that the performance of our method was better than
those of the RWR and DP_LCC methods. The table also shows a
comparison between our two methods, i.e., RWRMHRSS and
RWRAHRSS, and indicates that the latter performed better than
the former.
3.2. Effects of parameters
There is one free parameter in our method, namely, the restart
probability d in the RWR algorithm. We tested our algorithm with
different values of d (from 0 to 1 in steps of 0.2) and found that the
best performance was obtained with the restart parameter d ¼ 0:3.
With the different ds; the difference between the best AUC value
and the worst was less than 0.02. Therefore, d did not have a sub-
stantial inﬂuence on the results. Table 2 shows our experimental
results. The ROC curves for our methods at d ¼ 0:3 are shown in
Fig. 2. Fig. 2 shows that our RWRAHRSS method achieved slightly
better results than the RWRMHRSS method in the two test gene
sets. The results from Rand were always better than those from
ALI because the test gene set constructed by ALI was not always
included in the gene network. Together, these results demonstrate
the following: (1) our algorithm was robust in the selection of the
test gene set, and (2) increases in the numbers of known disease
genes result in better reﬂections of all aspects of the disease.
3.3. Predicting new disease genes for some common diseases
Parkinson’s disease (PD), also known as quiver paralytic disease,
is one of the most common neurodegenerative diseases. The
Table 2
AUC values of our method at different values of d.
Method 0.1 0.3 0.5 0.7 0.9
RWRAHRSS
ALI 0.8722 0.8737 0.8689 0.8615 0.8531
Rand 0.8929 0.8937 0.8913 0.8846 0.8768
RWRMHRSS
ALI 0.8587 0.8560 0.8517 0.8455 0.8385
Rand 0.8780 0.8795 0.8738 0.8701 0.8616
Fig. 2. ROC curves of our methods at d = 0.3.
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muscle rigidity, resting tremor, and gait abnormalities. In the
OMIM database, there are 4 genes associated with this disease that
include GBA, ADH1C, TBP, and MAPT. We used our method
(RWRAHRSS) to predict new disease genes for PD (MIM:
168600). The top 10 predictions for this disease were BAG5,
TIMM9, TIMM10, S100A5, PSPH, ADIPOQ, ADH5, PCSK9, CDH13,
and DNM1L. The ﬁrst prediction for PD was BAG5, which inhibits
parkin. Loss-of-function mutations in the parkin gene, which
encodes an E3 ubiquitin ligase, are the major causes of
early-onset Parkinson’s disease (PD) [28]. BAG5 plays a potential
role in the promotion of neurodegeneration in sporadic PD [29].
The last prediction was DNM1L, which is also known as DLP1,
DRP1, and EMPF. According to the report, the mutations of this
gene are associated with several neurological disorders [30].
DNM1L is a key protein in mitochondrial dynamics. Decreases in
this protein may interfere with neuron survival in PD [31].
Mitochondrial dysfunction represents an important event in the
pathogenesis of PD [32]. Moreover, DNM1L is one of the key regu-
lators of mitochondrial ﬁssion [33].
Breast cancer is a common malignancy that often occurs in
females. The clinical expression of breast cancer may include a
lump in the breast, a change in the breast shape, dimpling of the
skin, ﬂuid coming from the nipple, or a red scaly patch of skin.
According to the OMIM record, breast cancer (MIM: 114480) has
the following 23 validated causative genes: RAD54L, CASP8,
BARD1, PIK3CA, HMMR, NQO2, ESR1, RB1CC1, SLC22A1L, TSG101,
ATM, KRAS, BRCA2, XRCC3, AKT1, RAD51A, PALB2, CDH1, TP53,
PHB, PPM1D, BRIP1, and CHEK2. When we applied our method
(RWRAHRSS), the top 10 predictions for breast cancer were
PINK1, MSH5, TOP3A, RAD54L, DMC1, MLH3, PCCB, NMNAT1,
BLM, and CHEK2. The fourth prediction for breast cancer was
RAD54L. However, RAD54L has been proven to be the cause of
breast cancer in the latest OMIM database. This ﬁnding fully
demonstrates the effectiveness of our approach. BLM was another
prediction and is also a suspected causative gene for breast cancer[34,35]. BLM plays key roles in homologous recombination repair
and DNA replication. Some mutations in the BLM gene cause
Bloom’s syndrome, which leads to multiple cancers including
breast cancer [36]. The last prediction for breast cancer was
CHEK2. However, CHEK2 has also been proven to be the cause of
breast cancer in the latest OMIM database. This further illustrates
the effectiveness of our approach.
Obesity is a common, ancient metabolic syndrome. When the
body absorbs more calories than it consumes, the excess calories
are stored as fat. When fat exceeds the normal physiological
requirements, it reaches a certain value and results in obesity. In
the OMIM record, obesity (MIM: 601665) has the following 16 val-
idated causative genes: NR0B2, SDC3, POMC, GHRL, PPARG, UCP1,
CART, ADRB2, PPARGC1B, SIM1, ENPP1, ADRB3, UCP3, AGRP, PYY,
and MC4R. The top-10 predictions of our algorithm (RWRAHRSS)
for obesity were ADIPOQ, UCN, TYMS, NDP, CRH, GHRL, ADIPOR2,
CRHBP, NMUR2, and GIP. The ﬁrst prediction was ADIPOQ, which
plays an important role in regulating glucose levels and fatty acid
oxidation [37]. The literature indicates that ADIPOQ is closely
related to obesity [38,39]. Adiponectin is the protein that is
encoded by the ADIPOQ gene. It has been reported that low circu-
lating levels of adiponectin and single nucleotide polymorphisms
of ADIPOQ are associated with central obesity [40]. Another predic-
tion was CRH, which suppresses food intake and may be associated
with obesity [41]. Some studies have found that elevated placental
CRH is associated with childhood outcomes, such as increased adi-
ponectin levels and increased central adiposity [42]. Moreover, we
have described the relationship between adiponectin and central
obesity above.4. Conclusion
In the present paper, a method combining the topological sim-
ilarity in the PPI network and gene semantic similarity was pro-
posed for the prioritizing of candidate disease genes. The novelty
of our method lies in the incorporation of the gene semantic sim-
ilarity value to set the initial probability vector of the RWR. The
results of leave-one-out cross-validation on a benchmark dataset
revealed that the RWRAHRSS achieved a greater precision (as mea-
sured by the AUC) than the RWRMHRSS. This result indicates that
the use of greater numbers of known disease genes results in better
reﬂections of all aspects of the disease. Our method also outper-
formed the RWR and DP_LCC methods. Furthermore, we predicted
new causative genes for some common diseases, including
Parkinson’s disease, breast cancer, and obesity, with our algorithm
and found that a portion of the predictions were corroborated by
recent experimental reports. These results all prove the effective-
ness of our approach.
In our experiment, we found that the top (e.g., 20) identiﬁed
genes varied widely between these methods. We have explored
this phenomenon only from the perspective of information science.
The biological principle of this phenomenon remains unclear.
However, our team is applying the new method to the prediction
of disease genes, and this phenomenon will be examined and ana-
lyzed based on additional experimental results, which is also a part
of our future research.
The PPI network suffers from both high false positive and false
negative rates. As the PPI network becomes more perfect and GO
annotation information becomes more abundant, the prediction
results of our method will be better. Additionally, we can integrate
some other genomic information to further improve our method,
such as gene expression data and pathway membership data.
Moreover, many studies have suggested that a PPI network can
also be used to identify disease-related sub-networks. Thus, fur-
ther attention should be given to the modularity of disease.
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